1. Home
  2. IMRX vs ELA Comparison

IMRX vs ELA Comparison

Compare IMRX & ELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRX
  • ELA
  • Stock Information
  • Founded
  • IMRX 2008
  • ELA 1965
  • Country
  • IMRX United States
  • ELA United States
  • Employees
  • IMRX N/A
  • ELA N/A
  • Industry
  • IMRX Biotechnology: Pharmaceutical Preparations
  • ELA Consumer Specialties
  • Sector
  • IMRX Health Care
  • ELA Consumer Discretionary
  • Exchange
  • IMRX Nasdaq
  • ELA Nasdaq
  • Market Cap
  • IMRX 145.7M
  • ELA 156.2M
  • IPO Year
  • IMRX 2021
  • ELA N/A
  • Fundamental
  • Price
  • IMRX $4.18
  • ELA $6.03
  • Analyst Decision
  • IMRX Strong Buy
  • ELA Strong Buy
  • Analyst Count
  • IMRX 4
  • ELA 1
  • Target Price
  • IMRX $13.25
  • ELA $9.00
  • AVG Volume (30 Days)
  • IMRX 3.2M
  • ELA 68.0K
  • Earning Date
  • IMRX 08-05-2025
  • ELA 08-06-2025
  • Dividend Yield
  • IMRX N/A
  • ELA N/A
  • EPS Growth
  • IMRX N/A
  • ELA 15.15
  • EPS
  • IMRX N/A
  • ELA 0.28
  • Revenue
  • IMRX N/A
  • ELA $188,774,278.00
  • Revenue This Year
  • IMRX N/A
  • ELA $7.61
  • Revenue Next Year
  • IMRX N/A
  • ELA $6.27
  • P/E Ratio
  • IMRX N/A
  • ELA $21.45
  • Revenue Growth
  • IMRX N/A
  • ELA 14.19
  • 52 Week Low
  • IMRX $1.00
  • ELA $4.20
  • 52 Week High
  • IMRX $4.60
  • ELA $7.88
  • Technical
  • Relative Strength Index (RSI)
  • IMRX 68.29
  • ELA 58.58
  • Support Level
  • IMRX $3.95
  • ELA $6.00
  • Resistance Level
  • IMRX $4.55
  • ELA $6.35
  • Average True Range (ATR)
  • IMRX 0.42
  • ELA 0.26
  • MACD
  • IMRX 0.04
  • ELA 0.05
  • Stochastic Oscillator
  • IMRX 75.72
  • ELA 87.84

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

About ELA Envela Corporation

Envela Corp is a provider of recycling and re-commerce services at the forefront of the circular economy. These include re-commercializing luxury hard assets, consumer electronics and IT equipment; and end-of-life recycling solutions. It operates through two segments, Consumer, and Commercial Services. The Consumer segment which generates key revenue for the company predominantly buys to resell or recycle luxury hard assets like jewelry, diamonds, gemstones, fine watches, rare coins and related collectibles, precious-metal bullion products, gold, silver, and other precious metals. The Commercial Services segment provides asset-disposition solutions to government agencies, middle-market firms, corporations, and other organizations.

Share on Social Networks: